News on this topic
Profile picture of Truthout
Covax, the UN-Backed Vaccine Initiative, Is Reportedly Out of Money: Covax running out of money could spell potential disaster for low-income countries.
commondreams.org/news/2022/01/25/covax-out-cash-inadequacy-vaccine-charity-model-further-exposed
Covax, the UN-Backed Vaccine Initiative, Is Reportedly Out of Money
Profile picture of Reuters

Pfizer and BioNTech said they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicron variant ...  https://reut.rs/3o0zUPd

Profile picture of The Advocate
Pfizer testing updated COVID vaccines designed to protect against omicron variant
nola.com/news/coronavirus/vaccine/article_f77b1e3c-7dee-11ec-8245-a3bad943bf86.html
Pfizer testing updated COVID vaccines designed to protect against omicron ...
More news on this subject
Profile picture of Truthout
Covax, the UN-Backed Vaccine Initiative, Is Reportedly Out of Money: Covax running out of money could spell potential disaster for low-income countries.
commondreams.org/news/2022/01/25/covax-out-cash-inadequacy-vaccine-charity-model-further-exposed
Covax, the UN-Backed Vaccine Initiative, Is Reportedly Out of Money
Profile picture of The Advocate
Pfizer testing updated COVID vaccines designed to protect against omicron variant
nola.com/news/coronavirus/vaccine/article_f77b1e3c-7dee-11ec-8245-a3bad943bf86.html
Pfizer testing updated COVID vaccines designed to protect against omicron ...
Profile picture of WION
Top 10 world news: London police investigating Downing Street lockdown parties and more
wionews.com/world/top-10-world-news-london-police-investigating-downing-street-lockdown-parties-and-more-447498
Top 10 world news: London police investigating Downing Street lockdown ...
Profile picture of Kleine Zeitung
Biontech produces Omicron vaccine: how the adapted vaccines are approved: Omicron is the first variant of Sars-CoV-2 that results in adapted vaccines ...
kleinezeitung.at/lebensart/gesundheit/6089806/Biontech-produziert-OmikronVakzin_Wie-die-Zulassung-der
Biontech produces Omicron vaccine: how the adapted vaccines are approved
Profile picture of Westdeutsche Allgemeine Zeitung
Biontech takes big step - New corona vaccine coming soon?: The vaccine manufacturers have adapted their vaccine to the omicron variant. The vaccine could be ...
morgenpost.de/vermischtes/article234403827/biontech-corona-impfung-omikron-impfstoff.html
Biontech takes big step - New corona vaccine coming soon?
Profile picture of dk-online.de
High infection numbers: breakthrough in pandemic? Biontech and Pfizer start study on Omicron vaccine
noz.de/deutschland-welt/corona/artikel/biontech-und-pfizer-starten-klinische-studie-zu-omikron-impfstoff-21045876
High infection numbers: breakthrough in pandemic? Biontech and Pfizer ...
Profile picture of The Punch
COVID-19: School closures impact children’s mental health, nutrition –UNICEF - Healthwise
healthwise.punchng.com/covid-19-school-closures-impact-childrens-mental-health-nutrition-unicef/
COVID-19: School closures impact children’s mental health ...
Profile picture of allgemeine-zeitung.de
Mainz after the boom: Too many expenses and projects?: For two years, income in Mainz was bubbling. Now they are declining more than forecast ...
allgemeine-zeitung.de/lokales/mainz/stadt-mainz/mainz-nach-dem-boom-zu-viele-ausgaben-und-projekte-3405908
Mainz after the boom: Too many expenses and projects?
Profile picture of Frankfurter Allgemeine Zeitung
Vaccine: Biontech fuels hope in the fight against pancreatic cancer: The Mainz-based mRNA pioneer is working flat out on innovative therapies against cancer ...
faz.net/aktuell/wirtschaft/unternehmen/biontech-naehrt-hoffnung-im-kampf-gegen-bauchspeicheldruesenkrebs-19637578.html
Vaccine: Biontech fuels hope in the fight against pancreatic cancer
Quick Glance: Vaccine: Biontech's Hopeful Fight Against Pancreatic Cancer
  • Mainz-based mRNA pioneer works on innovative cancer treatments.

  • New study data show potential for personalized cancer vaccines.

  • Autogene Cevumeran triggers immune response in pancreatic cancer patients.

  • Biontech aims to improve treatment standards in oncology with mRNA-based vaccines.
Profile picture of nachrichten.at
Pancreatic cancer: Biontech reports initial successes with “vaccination”: Activated “killer cells” are intended to destroy tumor foci and prevent relapse
nachrichten.at/meine-welt/gesundheit/biontech-meldet-erste-erfolge-bei-impfung-gegen-pankreaskrebs;art114,3938755
Pancreatic cancer: Biontech reports initial successes with “vaccination”
Quick Glance: Hopeful Results in Pancreatic Cancer Treatment
  • Pancreatic cancer is among the most common cancers in Austria.

  • Biontech reports success with new vaccine BNT122 against the cancer.

  • Vaccine activates "killer cells" and prevents relapses.

  • Surgical removal and chemotherapy improve survival chances.
Profile picture of Frankfurter Allgemeine Zeitung
Vaccine: Biontech fuels hope in the fight against pancreatic cancer: The Mainz-based mRNA pioneer is working flat out on innovative therapies against cancer ...
faz.net/aktuell/wirtschaft/unternehmen/biontech-naehrt-hoffnung-im-kampf-gegen-bauchspeicheldruesenkrebs-19637578.html
Vaccine: Biontech fuels hope in the fight against pancreatic cancer
Quick Glance: Innovative Cancer Therapy: Biontech's Advancement
  • Biontech is actively developing over twenty cancer medications with promising results.

  • Current developments and potential market introductions of cancer treatments.

  • Significance of Biontech's promising results against pancreatic cancer.
Profile picture of inFranken.de
Breakthrough in cancer treatment? New data makes doctors euphoric: Could cancer soon be curable? A certain vaccine is showing initial positive effects in ...
infranken.de/ratgeber/gesundheit/durchbruch-in-der-krebsbehandlung-neue-daten-machen-mediziner-euphorisch-art-5855650
Breakthrough in cancer treatment? New data makes doctors euphoric
Profile picture of Die Weltwoche
"Misleading claims": The UK audit authority criticizes the pharmaceutical company Pfizer. The vaccine against Covid-19 was illegally advertised on social media ...
weltwoche.ch/daily/irrefuehrende-behauptungen-die-britische-pruefbehoerde-kritisiert-den-pharmakonzern-pfizer-in-den-sozialen-medien-sei-illegal-fuer-den-impfstoff-gegen-covid-19-geworben-worden/
Profile picture of allgemeine-zeitung.de
Red numbers after the boom: This is what Mainz's finances look like: After the Biontech boom, the Mainz budget slipped significantly into the red for the second ...
allgemeine-zeitung.de/lokales/mainz/stadt-mainz/rote-zahlen-nach-dem-boom-so-sehen-die-mainzer-finanzen-aus-3492267
Red numbers after the boom: This is what Mainz's finances look like
Profile picture of wiesbadener-kurier.de
Biontech is probably in the red this year: Biontech could end a financial year with losses in 2024 for the first time since the pandemic ...
wiesbadener-kurier.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-schreibt-dieses-jahr-wohl-rote-zahlen-3464126
Biontech is probably in the red this year
Quick Glance: Biontech: Financial Situation and Product Portfolio
  • Biontech is expected to slip into the red this year. Indications suggest that losses will be incurred.

  • Biontech launched an immunization campaign half a year ago in Mainz with posters encouraging medical consultation.

  • The company holds product aces, including vaccines and treatments combating diseases.

  • The financial status reflects predicted losses despite an array of promising products.
Profile picture of Süddeutsche Zeitung
Eli Lilly: billions invested in the pharmaceutical industry: Eli Lilly and other pharmaceutical companies are investing a lot of money in Germany. Why ...
sueddeutsche.de/wirtschaft/medikamente-eli-lilly-wacker-chemie-biontech-investitionen-vfa-deindustrialisierung-1.6531745
Eli Lilly: billions invested in the pharmaceutical industry
Profile picture of Berliner Zeitung
Things are getting tight for Ursula von der Leyen: criminal investigators are looking into the Pfizer deal
berliner-zeitung.de/wirtschaft-verantwortung/es-wird-eng-fuer-ursula-von-der-leyen-strafermittler-untersuchen-pfizer-deal-li.2201815
Things are getting tight for Ursula von der Leyen: criminal investigators ...
Profile picture of NPR
Drugmakers' low U.S. taxes belie their high sales: Most of the largest pharmaceutical companies report losing money in the United States ...
npr.org/sections/health-shots/2024/04/15/1244876740/drugmakers-low-taxes-us
Drugmakers' low U.S. taxes belie their high sales
Profile picture of Frankfurter Allgemeine Zeitung
Medicine and research: Why so many companies are investing in RNA technology: The three letters RNA represent a revolution in medicine. Companies from the ...
faz.net/aktuell/rhein-main/warum-so-viele-unternehmen-in-rna-investieren-19625909.html
Medicine and research: Why so many companies are investing in RNA ...
Profile picture of Die Weltwoche
Now the EU public prosecutor's office is also investigating von der Leyen - and the German media is still silent - The World Week
weltwoche.de/daily/nun-ermittelt-auch-die-eu-staatsanwaltschaft-gegen-von-der-leyen-und-die-deutschen-medien-schweigen-noch-immer/
Now the EU public prosecutor's office is also investigating von der Leyen ...
Profile picture of Focus (Polish magazine)
European prosecutors target von der Leyen over vaccine deals: The European Public Prosecutor’s Office has become involved in the “Pfizergate” scandal involving ...
focus.de/politik/pfizergate-europaeische-staatsanwaelte-nehmen-von-der-leyen-wegen-impfstoff-deals-ins-visier_id_259817356.html
European prosecutors target von der Leyen over vaccine deals
Profile picture of Neue Zürcher Zeitung
Investigation against von der Leyen over Pfizer deal: In 2021, the Commission President and Pfizer CEO Albert Bourla agreed a vaccine deal worth billions ...
nzz.ch/international/umstrittener-impfstoff-deal-nun-ermitteln-europas-korruptionsjaeger-gegen-ursula-von-der-leyen-ld.1824589
Investigation against von der Leyen over Pfizer deal
Profile picture of Barron's
Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.: Pfizer’s patent expirations are great for humanity but terrible for investors ...
barrons.com/articles/big-pharma-stocks-investors-mistakes-90e3c575
Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.
Profile picture of BÖRSE ONLINE
Morningstar reveals: These 10 moat stocks are the most undervalued: This list of 10 stocks has it all. According to the US experts at Morningstar ...
boerse-online.de/nachrichten/aktien/morningstar-gibt-preis-diese-10-burggraben-aktien-sind-am-staerksten-unterbewertet-20354078.html
Morningstar reveals: These 10 moat stocks are the most undervalued
Profile picture of Forbes
The 2024 Forbes Entrepreneurial CMO 50 List: By The Numbers: The data and details behind the CMOs and marketers making the 2024 Forbes Entrepreneurial CMO 50 ...
forbes.com/sites/sethmatlins/2024/04/15/the-2024-forbes-entrepreneurial-cmo-50-list-by-the-numbers/
The 2024 Forbes Entrepreneurial CMO 50 List: By The Numbers
Profile picture of Barron's
Pfizer RSV Vaccine Could Get Wider Use. New Study Suggests a Benefit For All Adults.
barrons.com/articles/pfizer-fda-rsv-vaccine-shot-gsk-moderna-4b1d50cc
Pfizer RSV Vaccine Could Get Wider Use. New Study Suggests a Benefit For ...
Profile picture of Quartz
Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales
qz.com/novavax-covid19-mrna-1851410267
Activist investor blasts Novavax for not using mRNA fears to boost ...
Quick Glance: Criticism of Novavax for Missed Opportunities in Boosting COVID-19 Vaccine Sales
  • Shah Capital called for immediate changes in the company's board.

  • The activist hedge fund Shah Capital criticized Novavax's leadership for not capitalizing on concerns some individuals have about mRNA vaccines to increase sales of its traditional, protein-based COVID-19 vaccine.

  • Findings from a survey of 1,500 Americans by the Annenberg Public Policy Center (APPC) at the University of Pennsylvania revealed an increase in the spread of vaccine misinformation.

  • The limited use of COVID-19 vaccines is also affecting other vaccine manufacturers. In the U.S., only 14% of adults have received an updated COVID-19 vaccine for 2023-2024, according to the Centers for Disease Control and Prevention.
Profile picture of Quartz
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug ...
Profile picture of BÖRSE ONLINE
Profile picture of Frankfurter Rundschau
RKI doubted AstraZeneca for months: “Less perfect”, “not a sure-fire success”, “2-class vaccination”
fr.de/politik/rki-protokolle-robert-koch-institut-corona-coronavirus-impfung-astrazeneca-zr-92921607.html
RKI doubted AstraZeneca for months: “Less perfect”, “not a sure-fire ...
Profile picture of Frankfurter Allgemeine Zeitung
Doubts about the Greek economic miracle: Greece is suffering from Europe's slump and needs further structural reforms. That is the tenor of the annual Delphi ...
faz.net/aktuell/wirtschaft/zweifel-am-griechischen-wirtschaftswunder-19651596.html
Doubts about the Greek economic miracle
Profile picture of Quartz
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug ...
Profile picture of Kölnische Rundschau
Vaccine deal with Pfizer: Ursula von der Leyen in the sights of corruption hunters
rundschau-online.de/red/impfstoff-deal-mit-pfizer-von-der-leyen-im-visier-der-korruptionsjaeger-770493
Vaccine deal with Pfizer: Ursula von der Leyen in the sights of corruption ...
Profile picture of DER AKTIONÄR
Pfizer: Enormous competition: The market is considered competitive.
deraktionaer.de/artikel/pharma-biotech/pfizer-enorme-konkurrenz-20354418.html
Pfizer: Enormous competition
Profile picture of BÖRSE ONLINE
Profile picture of The Seattle Times
Everett Seagen plant closure will cost 119 workers their jobs in June: The 119 impacted employees were working on the setup of the Seagen manufacturing plant in ...
seattletimes.com/business/everett-seagen-plant-closure-will-cost-119-workers-their-jobs-in-june/
Everett Seagen plant closure will cost 119 workers their jobs in June
Profile picture of Ad Age
Publicis New York hires new chief creative officer: Joe Mongognia will lead all creative across the Publicis New York office, including the newly won Pfizer ...
adage.com/article/agency-news/publicis-new-york-hires-joe-mongognia/2550746
Publicis New York hires new chief creative officer
Profile picture of Romania Insider
Romania still has 10 mln doses of COVID-19 vaccines expired or close to: Romania's minister of health, Alexandru Rafila, announced on April 1 that about 7 ...
romania-insider.com/romania-covid-vaccines-expired-april-2024
Romania still has 10 mln doses of COVID-19 vaccines expired or close to
Profile picture of japannews.yomiuri.co.jp
About 240 Mil. Unused COVID-19 Vaccine Doses to Be Discarded; Free Vaccination Program Ended
japannews.yomiuri.co.jp/society/coronavirus/20240402-178141/
About 240 Mil. Unused COVID-19 Vaccine Doses to Be Discarded; Free ...
Profile picture of Politico
European prosecutors take over Belgian probe into Pfizergate: European Public Prosecutor’s Office looking into texts between Ursula von der Leyen and boss of ...
politico.eu/article/pfizergate-covid-vaccine-scandal-european-prosecutors-eu-commission/
European prosecutors take over Belgian probe into Pfizergate
Profile picture of https://www.horizont.net
Horizon before 9: Eight things you should know this morning: Pfizer is completely consolidating its creative budget at Publicis, Martin Sorrell's agency holding ...
horizont.net/marketing/horizont-vor-neun/horizont-vor-9-acht-dinge-die-sie-heute-morgen-wissen-sollten-218910
Horizon before 9: Eight things you should know this morning
Profile picture of Oberhessische Presse
Biontech: Bringing the first cancer drug onto the market in 2026: The Mainz company Biontech is known for its Covid-19 vaccine - and rich - become ...
op-marburg.de/gesundheit/biontech-erstes-krebs-medikament-2026-auf-den-markt-bringen-KIDG6SA66BLXRM2UL6P2I6UBSY.html
Biontech: Bringing the first cancer drug onto the market in 2026
Quick Glance: BioNTech Focuses on Cancer Drug Development after Revenue Plunge
  • BioNTech reported a significant drop in revenue and earnings in 2023 as it shifts focus towards cancer drug development.

  • The company aims for revenues between 2.5 billion to 3.1 billion euros in 2024.

  • BioNTech plans to launch its first oncology drug in 2026 and secure ten indication approvals by 2030.

  • Partner Pfizer anticipates a decline in sales for the COVID-19 vaccine, while BioNTech invests in scaling up its oncology business.
Profile picture of Capital (German magazine)
Biontech's business collapses massively: buy shares cheaply now?: Corona is over, and the numbers and share price at vaccine manufacturer Biontech are collapsing ...
capital.de/geld-versicherungen/biontechs-geschaeft-bricht-massiv-ein--aktie-jetzt-guenstig-kaufen--34561014.html
Biontech's business collapses massively: buy shares cheaply now?
Quick Glance: Biontech: Massive Business Decline Post-COVID
  • As COVID ends, Biontech faces declining numbers and stock prices.

  • A study reveals the significant impact of COVID on life expectancy.

  • Biontech gained global recognition with the mRNA vaccine.

  • The company is now focusing on new treatments for cancer to bounce back.
Profile picture of BÖRSE ONLINE
Does she know more? Star investor Cathie Wood has just signed up for this BioNTech competitor
boerse-online.de/nachrichten/aktien/weiss-sie-mehr-bei-diesem-biontech-konkurrent-hat-cathie-wood-gerade-zugeschlagen-20353621.html
Does she know more? Star investor Cathie Wood has just signed up for this ...
Profile picture of Die Rheinpfalz
Sick after coronavirus vaccination? Palatinate man goes to court: A man from Pirmasens takes Biontech to court. Because he has suffered serious damage to his ...
rheinpfalz.de/lokal/pirmasens_artikel,-krank-nach-corona-impfung-pf%C3%A4lzer-zieht-vor-gericht-_arid,5628342.html
Sick after coronavirus vaccination? Palatinate man goes to court
Profile picture of BÖRSE ONLINE
Profile picture of Süddeutsche Zeitung
Munich: Major Biontech shareholders buy “Fünf Höfe” - for almost 800 million euros
sueddeutsche.de/muenchen/muenchen-fuenf-hoefe-verkauf-biontech-grossaktionaere-1.6472720
Munich: Major Biontech shareholders buy “Fünf Höfe” - for almost 800 ...
Profile picture of wiesbadener-kurier.de
Biontech competitor Curevac cuts jobs in the region: High losses and a stock market crash: Curevac shows what could have happened to Biontech if the Mainz-based ...
wiesbadener-kurier.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-konkurrent-curevac-baut-stellen-in-der-region-ab-3428188
Biontech competitor Curevac cuts jobs in the region
Profile picture of CNBC
Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
cnbc.com/2024/03/10/pfizer-is-betting-big-on-cancer-drugs-after-covid-decline.html
Pfizer is betting big on cancer drugs to turn business around after Covid ...
Profile picture of Rhein-Zeitung
After "golden years" for Idar-Oberstein: where have the millions gone?: Idar-Oberstein. Where have the Biontech millions gone? Where have they gone? Why is ...
rhein-zeitung.de/region/aus-den-lokalredaktionen/nahe-zeitung_artikel,-nach-goldenen-jahren-fuer-idaroberstein-wo-sind-die-millionen-hin-_arid,2629992.html
After
Profile picture of ProPublica
Syphilis Is Killing Babies. The U.S. Government Is Failing to Stop the Disease From Spreading.
propublica.org/article/how-federal-government-fails-stop-syphilis-babies-pregnancy
Syphilis Is Killing Babies. The U.S. Government Is Failing to Stop the ...
Profile picture of ABC News
Why COVID-19 patients who could most benefit from Paxlovid still aren’t getting it
abcnews.go.com/Health/covid-19-patients-benefit-paxlovid-arent/story
Why COVID-19 patients who could most benefit from Paxlovid still aren’t ...
Profile picture of ABC News
COVID-19 timeline: How the deadly virus and the world's response have evolved over 4 years
abcnews.go.com/Health/covid-19-timeline-deadly-virus-worlds-response-evolved/story
COVID-19 timeline: How the deadly virus and the world's response have ...
Profile picture of Forbes
What To Know About Adcetris—Pfizer’s Cancer Drug Extended Survival For Patients With Common Lymphoma
forbes.com/sites/tylerroush/2024/03/12/what-to-know-about-adcetris-pfizers-cancer-drug-extended-survival-for-patients-with-common-lymphoma/
What To Know About Adcetris—Pfizer’s Cancer Drug Extended Survival For ...
Profile picture of Reuters
Group suing over Pfizer diversity fellowship program loses US appeal: A U.S. appeals court on Wednesday upheld the dismissal of a lawsuit by a conservative group ...
reut.rs/48IEJ4c
Group suing over Pfizer diversity fellowship program loses US appeal
Profile picture of PBS
Measles cases are rising in the U.S. Here’s why misinformation about the vaccine persists today
pbs.org/newshour/health/measles-cases-are-rising-in-the-u-s-heres-why-misinformation-about-the-vaccine-persists-today
Measles cases are rising in the U.S. Here’s why misinformation about the ...
Quick Glance: Measles Cases Surge in the U.S.
  • Global measles cases are rising despite the available vaccine, reflecting declining vaccine confidence.

  • Critics say prominent statements are fueling vaccine hesitancy. Epidemiologists warn of severe outcomes during outbreaks.

  • Exemption rates above 5 percent lead to lower vaccination coverage, increasing the risk for outbreaks.

  • Experts caution about the rising spread of measles due to declining vaccination rates and the impact of misinformation in the COVID era.
Profile picture of The Guardian
‘Hypervaccinated’ man reportedly received 217 Covid jabs without side-effects: The 62-year-old, from Germany said he had the large number of vaccines for ...
theguardian.com/society/2024/mar/06/hypervaccinated-man-217-covid-jabs-no-side-effects-germany
‘Hypervaccinated’ man reportedly received 217 Covid jabs without ...
Profile picture of CNBC
CNBC Daily Open: A mixed picture on U.S. jobs growth : U.S. jobs growth continues to boom but there are also clear signs the labor market is cooling.
cnbc.com/2024/03/11/cnbc-daily-open-a-mixed-picture-on-us-jobs-growth-.html
CNBC Daily Open: A mixed picture on U.S. jobs growth
Profile picture of The Hill (newspaper)
Measles outbreak threatens US status of ‘eliminating’ virus: The rash of measles outbreaks around the country has sparked concerns that the U.S ...
thehill.com/policy/healthcare/4517298-measles-outbreak-us-status-elimination/
Measles outbreak threatens US status of ‘eliminating’ virus
Profile picture of ITVX
Children 'suffering needlessly' due to lower vaccine uptake and measles spike: Experts said vaccines had become a ‘victim of their own success’.
itv.com/news/2024-02-29/children-suffering-needlessly-due-to-lower-vaccine-uptake-and-measles-spike
Children 'suffering needlessly' due to lower vaccine uptake and measles ...
Profile picture of PBS
How vaccine hesitancy is contributing to rising rates of measles and COVID: Vaccines have been proven to be an effective weapon against many diseases. Measles ...
pbs.org/newshour/show/how-vaccine-hesitancy-is-contributing-to-rising-rates-of-measles-and-covid
How vaccine hesitancy is contributing to rising rates of measles and COVID
Profile picture of Bloomberg
Pfizer (PFE) Syphilis Drug Bicillin L-A Shortage to Extend Into At Least October: The US shortage of Pfizer Inc.’s drug that’s the optimal treatment for syphilis ...
bloomberg.com/news/articles/2024-03-08/shortage-of-pfizer-syphilis-drug-will-continue-longer-than-expected
Pfizer (PFE) Syphilis Drug Bicillin L-A Shortage to Extend Into At Least ...
Profile picture of Politico
Florida GOP senators defend DeSantis’ surgeon general amid measles outbreak: The measles outbreak shows the further polarization of vaccines.
politico.com/news/2024/03/04/florida-measles-ladapo-desantis-00144561
Florida GOP senators defend DeSantis’ surgeon general amid measles ...